Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Looking for a different delivery format
The key is regular monitoring via lab work and clinical assessment
Note that Bydureon is not recommended as first-line therapy for patients who have inadequate glycemic control on diet and exercise because of the uncertain relevance of the rat thyroid C-cell tumor findings to humans (Drugs.com)
The new research, published Monday (Nov
De Leon DD, Farzad C, Crutchlow MF, Brestelli J, Tobias J, Kaestner KH, and Stoffers DA
US$ 27.30
US$ 20.13
US$ 23.32
US$ 28.91
US$ 26.45
US$ 20.42
US$ 25.23
US$ 24.43
US$ 27.25
US$ 27.10
